John G. Ullman & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $778K | Sell |
7,019
-2
| -0% | -$222 | 0.12% | 106 |
|
2025
Q1 | $787K | Buy |
7,021
+1,786
| +34% | +$200K | 0.12% | 112 |
|
2024
Q4 | $484K | Buy |
5,235
+257
| +5% | +$23.7K | 0.07% | 129 |
|
2024
Q3 | $417K | Hold |
4,978
| – | – | 0.06% | 143 |
|
2024
Q2 | $342K | Buy |
4,978
+500
| +11% | +$34.3K | 0.05% | 151 |
|
2024
Q1 | $328K | Buy |
4,478
+700
| +19% | +$51.3K | 0.05% | 141 |
|
2023
Q4 | $306K | Sell |
3,778
-72
| -2% | -$5.83K | 0.05% | 140 |
|
2023
Q3 | $289K | Sell |
3,850
-100
| -3% | -$7.49K | 0.05% | 148 |
|
2023
Q2 | $304K | Hold |
3,950
| – | – | 0.05% | 149 |
|
2023
Q1 | $328K | Sell |
3,950
-24
| -0.6% | -$1.99K | 0.05% | 150 |
|
2022
Q4 | $341K | Buy |
3,974
+124
| +3% | +$10.6K | 0.05% | 143 |
|
2022
Q3 | $238K | Hold |
3,850
| – | – | 0.04% | 147 |
|
2022
Q2 | $238K | Buy |
3,850
+50
| +1% | +$3.09K | 0.04% | 151 |
|
2022
Q1 | $226K | Hold |
3,800
| – | – | 0.03% | 157 |
|
2021
Q4 | $276K | Buy |
+3,800
| New | +$276K | 0.04% | 144 |
|
2020
Q4 | – | Sell |
-3,665
| Closed | -$232K | – | 157 |
|
2020
Q3 | $232K | Buy |
+3,665
| New | +$232K | 0.05% | 115 |
|
2019
Q4 | – | Sell |
-4,780
| Closed | -$303K | – | 149 |
|
2019
Q3 | $303K | Sell |
4,780
-915
| -16% | -$58K | 0.06% | 119 |
|
2019
Q2 | $385K | Buy |
5,695
+2,495
| +78% | +$169K | 0.07% | 109 |
|
2019
Q1 | $208K | Sell |
3,200
-200
| -6% | -$13K | 0.04% | 124 |
|
2018
Q4 | $213K | Buy |
3,400
+200
| +6% | +$12.5K | 0.04% | 122 |
|
2018
Q3 | $247K | Buy |
+3,200
| New | +$247K | 0.04% | 116 |
|
2015
Q2 | – | Sell |
-2,069
| Closed | -$203K | – | 147 |
|
2015
Q1 | $203K | Buy |
+2,069
| New | +$203K | 0.04% | 133 |
|
2014
Q4 | – | Sell |
-2,119
| Closed | -$226K | – | 146 |
|
2014
Q3 | $226K | Buy |
+2,119
| New | +$226K | 0.04% | 136 |
|